miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease
Objective: Non-alcoholic fatty liver disease (NAFLD) is a complex pathology in which several dysfunctions, including alterations in metabolic pathways, mitochondrial functionality and unbalanced lipid import/export, lead to lipid accumulation and progression to inflammation and fibrosis. The enzyme...
Saved in:
Similar Items
-
Methionine Cycle Rewiring by Targeting miR-873-5p Modulates Ammonia Metabolism to Protect the Liver from Acetaminophen
by: Rubén Rodríguez-Agudo, et al.
Published: (2022) -
The Case for GNMT as a Biomarker and a Therapeutic Target in Pancreatic Cancer
by: Zachary Heinzman, et al.
Published: (2021) -
The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers
by: Hamada A. Mokhlis, et al.
Published: (2019) -
Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis
by: Marina Serrano-Maciá, et al.
Published: (2021) -
ABU AL-HASAN AL-ASY'ARI (873-935):PEMIKIRAN DAN PENGARUHNYADALAM TEOLOGI ISLAM
by: Miftah Faturohman, -
Published: (2008)